{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:34:00Z","timestamp":1789475640553,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":2559,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.7861\/clinmedicine.17-2-132","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T08:55:22Z","timestamp":1491036922000},"page":"132-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Proton pump inhibitor failure in gastro-oesophageal reflux disease: a perspective aided by the Gartner hype cycle"],"prefix":"10.1016","volume":"17","author":[{"given":"Robert C","family":"Heading","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.7861\/clinmedicine.17-2-132_bib1","series-title":"Mastering the hype cycle","author":"Fenn","year":"2008"},{"key":"10.7861\/clinmedicine.17-2-132_bib2","series-title":"Clinical pharmacology","author":"Laurence","year":"1960"},{"key":"10.7861\/clinmedicine.17-2-132_bib3","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1053\/gast.1997.v112.pm9178669","article-title":"Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis","volume":"112","author":"Chiba","year":"1997","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmedicine.17-2-132_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1365-2036.1998.00418.x","article-title":"A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects","volume":"12","author":"Williams","year":"1998","journal-title":"Aliment Pharmacol Therap"},{"key":"10.7861\/clinmedicine.17-2-132_bib5","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1572-0241.2003.07531.x","article-title":"Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association","volume":"98","author":"Shaker","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmedicine.17-2-132_bib6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-2036.2010.04406.x","article-title":"Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies","volume":"32","author":"El-Serag","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.7861\/clinmedicine.17-2-132_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2036.2006.02982.x","article-title":"Persistence and adherence to proton pump inhibitors in daily clinical practice","volume":"24","author":"Van Soest","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.7861\/clinmedicine.17-2-132_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cgh.2011.07.008","article-title":"Systematic review: patterns of proton pump inhibitor use and adherence in gastroesophageal reflux disease","volume":"10","author":"Hungin","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.7861\/clinmedicine.17-2-132_bib9","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/ajg.2011.146","article-title":"Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease","volume":"106","author":"Kahrilas","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmedicine.17-2-132_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1572-0241.2001.03451.x","article-title":"Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease","volume":"96","author":"Shaw","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmedicine.17-2-132_bib11","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.cgh.2011.05.015","article-title":"Insights into gastroesophageal reflux disease-associated dyspeptic symptoms","volume":"9","author":"Gerson","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.7861\/clinmedicine.17-2-132_bib12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0399-8320(06)73189-X","article-title":"Gastroesophageal reflux disease in primary care. Prevalence, epidemiology and quality of life of patients","volume":"30","author":"Bruley des Varannes","year":"2006","journal-title":"Gastroenterol Clin Biol"},{"key":"10.7861\/clinmedicine.17-2-132_bib13","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s10620-008-0594-2","article-title":"Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS) \u2013 is It one disease or an overlap of two disorders?","volume":"54","author":"Gasiorowska","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.7861\/clinmedicine.17-2-132_bib14","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2036.2007.03366.x","article-title":"Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population","volume":"26","author":"Jung","year":"2007","journal-title":"Aliment Pharmacol Therap"},{"key":"10.7861\/clinmedicine.17-2-132_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000219365","article-title":"Diagnosis and management of non-erosive reflux disease \u2013 the Vevey NERD consensus group","volume":"80","author":"Modlin","year":"2009","journal-title":"Digestion"},{"key":"10.7861\/clinmedicine.17-2-132_bib16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1053\/gast.2001.27997","article-title":"Unbuffered highly acidic gastric juice exists at the gastro-oesophageal junction after a meal","volume":"121","author":"Fletcher","year":"2001","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmedicine.17-2-132_bib17","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/j.1572-0241.2006.00711.x","article-title":"Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy","volume":"101","author":"Zerbib","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmedicine.17-2-132_bib18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/j.gastro.2010.08.023","article-title":"Safety of proton pump inhibitor exposure","volume":"139","author":"Yang","year":"2010","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmedicine.17-2-132_bib19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10620-010-1560-3","article-title":"Adverse effects of long-term proton pump inhibitor therapy","volume":"56","author":"Sheen","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.7861\/clinmedicine.17-2-132_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/11531320-000000000-00000","article-title":"Drug-drug interaction profiles of proton pump inhibitors","volume":"49","author":"Ogawa","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.7861\/clinmedicine.17-2-132_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0016-5085(99)70118-6","article-title":"Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status","volume":"116","author":"Gillen","year":"1999","journal-title":"Gastroenterlogy"},{"key":"10.7861\/clinmedicine.17-2-132_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.gastro.2009.03.058","article-title":"Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy","volume":"137","author":"Reimer","year":"2009","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmedicine.17-2-132_bib23","series-title":"Making sense of the adverse effects of PPIs","author":"Moayyedi","year":"2016"},{"key":"10.7861\/clinmedicine.17-2-132_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/gut.32.2.128","article-title":"Symptomatic gastro-oesophageal reflux, abnormal oesophageal acid exposure, and mucosal acid sensitivity are three separate, though related, aspects of gastro-oesophageal reflux disease","volume":"32","author":"Howard","year":"1991","journal-title":"Gut"},{"key":"10.7861\/clinmedicine.17-2-132_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/gut.37.4.457","article-title":"Galmiche JP Reflux related symptoms in patients with normal oesophageal exposure to acid","volume":"37","author":"Shi","year":"1995","journal-title":"Gut"},{"key":"10.7861\/clinmedicine.17-2-132_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/00365520510011579","article-title":"High prevalence of gastroesophageal reflux symptoms and esophagitis with and without symptoms in the general adult Swedish population: a Kalixanda study report","volume":"40","author":"Ronkainen","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.7861\/clinmedicine.17-2-132_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2466-13-33","article-title":"Response of the airways and autonomic nervous system to acid perfusion of the esophagus in patients with asthma: a laboratory study","volume":"13","author":"Amarasiri","year":"2013","journal-title":"BMC Pulm Med"},{"key":"10.7861\/clinmedicine.17-2-132_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2036.2006.02987.x","article-title":"Oesophageal acid exposure and altered neurocardiac function in patients with GERD and idiopathic cardiac dysrhythmias","volume":"24","author":"Cuomo","year":"2006","journal-title":"Aliment Pharmacol Therap"},{"key":"10.7861\/clinmedicine.17-2-132_bib29","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/BF02212678","article-title":"Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity","volume":"40","author":"Trimble","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.7861\/clinmedicine.17-2-132_bib30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/gut.51.6.885","article-title":"Functional heartburn: the stimulus, the pain and the brain","volume":"51","author":"Fass","year":"2002","journal-title":"Gut"},{"key":"10.7861\/clinmedicine.17-2-132_bib31","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2016.02.012","article-title":"Functional esophageal disorders","volume":"150","author":"Aziz","year":"2016","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmedicine.17-2-132_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-230X-11-52","article-title":"Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole","volume":"11","author":"Heading","year":"2011","journal-title":"BMC Gastroenterol"},{"key":"10.7861\/clinmedicine.17-2-132_bib33","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.cgh.2014.11.034","article-title":"Effects of anxiety and depression in patients with gastroesophageal reflux disease","volume":"13","author":"Kessing","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.7861\/clinmedicine.17-2-132_bib34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cgh.2014.04.003","article-title":"Proton pump inhibitors reduce the size and acidity of the acid pocket in the stomach","volume":"12","author":"Rohof","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.7861\/clinmedicine.17-2-132_bib35","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/gutjnl-2011-300926","article-title":"Effect of azithromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period","volume":"61","author":"Rohof","year":"2012","journal-title":"Gut"},{"key":"10.7861\/clinmedicine.17-2-132_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2036.2011.04678.x","article-title":"An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial \u2018acid pocket\u2019 in symptomatic GERD patients","volume":"34","author":"Kwiatek","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.7861\/clinmedicine.17-2-132_bib37","series-title":"NICE clinical guideline No 184","article-title":"Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management","year":"2014"},{"key":"10.7861\/clinmedicine.17-2-132_bib38","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/nmo.12666","article-title":"Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux","volume":"27","author":"Roman","year":"2015","journal-title":"Neurogastroenterol Motil"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824019511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824019511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmedicine.17-2-132","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:35:51Z","timestamp":1761460551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824019511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1470211824019511"],"URL":"https:\/\/doi.org\/10.7861\/clinmedicine.17-2-132","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton pump inhibitor failure in gastro-oesophageal reflux disease: a perspective aided by the Gartner hype cycle","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmedicine.17-2-132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2017. All rights reserved.","name":"copyright","label":"Copyright"}]}}